Medtronic plc (MDT)
Medtronic is a global healthcare giant that designs and manufactures medical devices, from heart pacemakers to surgical robots, to help people live healthier lives.
Is Medtronic plc a good stock for a UK beginner?
The honest version: Medtronic is a global healthcare giant that designs and manufactures medical devices, from heart pacemakers to surgical robots, to help people live healthier lives.
Over about 2 years to 2026-07-31. This is the share price only - reinvesting the dividends would add to it. And it's the USD return - as a UK investor your actual £ return also moves with the exchange rate. Past performance is not a guide to the future, and it could just as easily have fallen.
Based on beta - how much the price swings versus the whole market. Bumpier isn't bad; it just means a rougher ride, which matters more the sooner you might need the money.
Prices move on results, news and the mood of the whole market - no single headline explains a day, and a quiet week is usually just noise, not a signal.
Dominance in the growing market for remote patient monitoring.
Major technological disruption from new, smaller competitors.
What does Medtronic plc do?
Medtronic makes the high-tech tools that doctors use every day, including insulin pumps, heart valves, and surgical equipment. The company earns its keep selling these essential devices to hospitals and clinics around the world. Watch how well Medtronic keeps innovating across its product range, since staying ahead of rivals in fast-moving medical technology is what counts here.
On our factor screen it looks strongest on value and quality, and weakest on momentum.
- ✓Pays a dividend - about 3.4% a year
- ✓Growing - revenue up about 10% over the year
- A massive, established player with a very wide range of medical products.
- High gross margins suggest they have strong control over their pricing.
- A history of paying a reliable dividend to shareholders.
- Strict government regulations can delay or block new product launches.
- Potential for expensive legal issues if medical devices fail or cause harm.
- Economic downturns can lead hospitals to delay purchasing expensive new equipment.
What do Medtronic plc's numbers mean?
How much money does Medtronic plc make?
Revenue and profit by quarter, and how much of each sale turns into profit.
Does Medtronic plc pay a dividend?
Yes - Medtronic plc currently pays a dividend of about 3.4% a year (the yearly payout as a share of the price). A dividend is a slice of profit handed to shareholders; the yield moves as the price moves, and a company can cut or stop it.
When does Medtronic plc report earnings, and how did recent quarters go?
Medtronic plc is next scheduled to report on about 2026-09-01 - dates can move, and we don't predict results; this just tells you when to look.
Each quarter a company reports its results against what analysts expected. ‘Beating’ or ‘missing’ is about that expectation, not whether the business is doing well in absolute terms.
| Reported | Expected EPS: The earnings per share analysts expected for the quarter - the average of their forecasts. 'Beating' or 'missing' is measured against this number. | Actual EPS | vs expected |
|---|---|---|---|
| 2026-06-03 | $1.54 | $1.55 | In line |
| 2026-02-17 | $1.34 | $1.36 | Beat +2% |
| 2025-11-18 | $1.31 | $1.36 | Beat +3% |
| 2025-08-19 | $1.23 | $1.26 | Beat +3% |
| 2025-05-21 | $1.58 | $1.62 | Beat +3% |
| 2025-02-18 | $1.36 | $1.39 | Beat +2% |
Across the last 6 quarters here, Medtronic plc came in ahead of what analysts expected 5 times. One quarter is noise, not a trend.
See who else reports over the next two weeks →
Reported vs expected earnings per share (EPS) from published results; the expectation is the analyst consensus, not our view. Report dates are estimates that can move.
More in Healthcare
Eli Lilly
West Pharmaceutical Services, Inc.
Incyte Corporation
The Cigna Group
Zimmer Biomet Holdings, Inc.
Moderna, Inc.
Gilead Sciences, Inc.
Regeneron Pharmaceuticals, Inc.What are the scenarios for Medtronic plc?
An illustrative range for the year ahead, with the assumption behind each case — not a prediction or a price target.
What are the pros and cons of Medtronic plc?
How many points the write-up makes each way — a balance check, not a score or verdict.
- A massive, established player with a very wide range of medical products.
- High gross margins suggest they have strong control over their pricing.
- A history of paying a reliable dividend to shareholders.
- Lower volatility compared to the broader market.
- Large, complex companies can be slow to adapt to rapid changes.
- Heavy reliance on hospital budgets which can be squeezed by government policy.
- High competition in the medical device sector keeps pressure on profit margins.
- Strict government regulations can delay or block new product launches.
- Potential for expensive legal issues if medical devices fail or cause harm.
- Economic downturns can lead hospitals to delay purchasing expensive new equipment.
The write-up's own warning lights — if these start happening, the case above changes.
- A significant, sustained drop in their gross profit margins.
- A major regulatory failure leading to a widespread product recall.
Built from public filings & market prices, checked for an education-only tone, and never a price target. How we make these →
This plain-English summary was auto-generated on 2026-08-01 from public data and checked for an education-only, no-advice tone (the figures above carry their own, usually fresher, 'as of' date). It's information, never a recommendation.